D-0251-2021 Class III Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0251-2021 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Feb 5, 2021 and is designated Class III. Reason for recall: Failed Impurity/Degradation Specifications The recall status is terminated (terminated Nov 3, 2021). Affected quantity: 20,475 vials.

Recall details

Product Type
Drugs
Report Date
Feb 17, 2021
Initiation Date
Feb 5, 2021
Termination Date
Nov 3, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
20,475 vials

Product description

Pantoprazole Sodium for Injection 40mg/vial For I.V. infusion only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 62756-129-40

Reason for recall

Failed Impurity/Degradation Specifications

Distribution pattern

Nationwide

Code information

JKU3595A, JKU3596A, JKU3597A, and JKU3629A; Exp 02/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0251-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0251-2021. Report a data issue: hello@regdatalab.com.